-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Prelude Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
- Prelude Therapeutics Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 75.9M shares, a 12.1% increase year-over-year.
- Prelude Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 60.4M shares, a 27.4% increase from 2022.
- Prelude Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 47.4M shares, a 2.87% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)